| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/11/2002 | WO2001085207A3 Modulation of antigen processing using phagocytic cells |
| 07/11/2002 | WO2001079445A3 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 07/11/2002 | WO2001076556A3 Lipid-based drug delivery systems against parasitic infections |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001043540A3 Methods for producing transgenic animals |
| 07/11/2002 | WO2001034205A3 Use of lytic toxins and toxin conjugates |
| 07/11/2002 | WO2001032159A3 Methods and formulations for the treatment of infectious bursal disease in avian subjects |
| 07/11/2002 | WO2001030392A3 Delivery of proteins across polar epithelial cell layers |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001021213A3 Inhibition of secretion from non-neuronal cells |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | WO2000075173A3 Peptide fragments of colostrinin |
| 07/11/2002 | WO2000075144A9 Peroxynitrite decomposition catalysts and methods of use thereof |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000073263A9 Cytofectin dimers and methods of use thereof |
| 07/11/2002 | WO2000066179A9 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 07/11/2002 | WO2000064488A9 Somatic transgene immunization and related methods |
| 07/11/2002 | US20020091270 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 07/11/2002 | US20020091263 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 07/11/2002 | US20020091259 Compounds useful as reversible inhibitors of cathepsin S |
| 07/11/2002 | US20020091251 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 07/11/2002 | US20020091246 Dendritic cell co-stimulatory molecules |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091240 Humanized antibodies to gamma-interferon |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091153 Novel anandamide amidase inhibitors as analgesic agents |
| 07/11/2002 | US20020091145 Behavior chemotherapy |
| 07/11/2002 | US20020091143 Use of 4-substituted tetrahydropyridines for the manufacture of medicament s acting upon TGF-beta 1 |
| 07/11/2002 | US20020091127 Semicarbazides and their uses |
| 07/11/2002 | US20020091121 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 07/11/2002 | US20020091115 Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
| 07/11/2002 | US20020091105 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB. |
| 07/11/2002 | US20020091079 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants |
| 07/11/2002 | US20020090724 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease |
| 07/11/2002 | US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 07/11/2002 | US20020090402 Having anti-allergic effect, which can also be used as an immune regulator |
| 07/11/2002 | US20020090384 Anti-irritant compositions containing a cyclic nucleotide |
| 07/11/2002 | US20020090381 System for controlling immune system response to antigen |
| 07/11/2002 | US20020090379 Poviding self-protein analog by molecular biological means by substitution of one or more peptide fragments of self-protein by corresponding number of peptides known to contain immunodominant foreign T-cell epitopes |
| 07/11/2002 | US20020090375 Stratified and cryogenically stored vaccines, process for their preparation |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090371 Orally or enterally administering to the mammal an effective immunosuppressive dose of a plant material derived from a plant transformant capable of producing antigen or an immunosuppressive fragment or its derivative |
| 07/11/2002 | US20020090370 Novel porcine protein and uses thereof |
| 07/11/2002 | US20020090352 Compositions and methods for use in modulating immune system function |
| 07/11/2002 | DE10064732A1 Enterale Zubereitung zur Stärkung des Immunsystems Enteral preparation for strengthening the immune system |
| 07/11/2002 | CA2708949A1 Immunizing compositions and methods of use |
| 07/11/2002 | CA2439730A1 Benzofuran derivatives and pharmaceutical compositions containing the same |
| 07/11/2002 | CA2434118A1 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | CA2433828A1 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | CA2433794A1 Uses for polycationic compounds as vaccine adjuvants |
| 07/11/2002 | CA2433561A1 Compositions including gram negative siderophore receptor proteins and methods of use |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | CA2433125A1 Medicament containing a polyamine as an active substance |
| 07/11/2002 | CA2433041A1 Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty |
| 07/11/2002 | CA2432409A1 Tropolone derivative |
| 07/11/2002 | CA2431662A1 A method for the manufacture of compositions containing low concentrations of salts |
| 07/11/2002 | CA2431041A1 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | CA2429636A1 Group 2 allergen specific ige-fabs and igg molecules and use thereof |
| 07/11/2002 | CA2428351A1 Method for detoxifying a carbohydrate containing solution |
| 07/10/2002 | EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
| 07/10/2002 | EP1221488A1 Stress proteins and uses therefor |
| 07/10/2002 | EP1221483A1 NF-AT polypeptides and polynucleotides |
| 07/10/2002 | EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/10/2002 | EP1221317A1 Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins |
| 07/10/2002 | EP1221316A1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 07/10/2002 | EP1221315A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 07/10/2002 | EP1220897A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220845A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220840A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220684A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220680A2 Echinacea supplement and method of manufacture |
| 07/10/2002 | EP1220674A1 Pharmaceutical product suitable for use immunosuppressive therapy |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/10/2002 | EP1220611A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 07/10/2002 | EP0812206B1 Cd40 binding protein for stimulating an immune response |
| 07/10/2002 | EP0789576B1 Extract of crataegus and its use |